Companies /Healthcare

Edwards Lifesciences Corp

NYSE: EW Medical Devices
$90.20
▼ $0.58 (−0.64%) today
Markets open · 3:40pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$52.3B
P/E Ratio
54.0
Profit Margin
15.4%
Revenue (TTM)
$6.5B
EPS (TTM)
$1.68
52-Week Range
$72 – $96
Street Target
$100.96

About Edwards Lifesciences

Edwards Lifesciences Corp specializes in innovative solutions for heart disease and critical care monitoring worldwide. It's known for its Edwards SAPIEN family of valves, offering minimally invasive aortic valve replacements. The company also tackles mitral and tricuspid valve diseases with its PASCAL PRECISION and Cardioband systems. Beyond valve solutions, Edwards provides surgical and critical care products like the INSPIRIS RESILLA aortic valve and advanced hemodynamic monitoring systems. Founded in 1958 and based in Irvine, California, Edwards Lifesciences is a pioneer in improving patient outcomes in heart care and intensive care units.

EW Coverage